Page last updated: 2024-08-05 10:50:40
tyrosine derivative
An amino acid derivative resulting from reaction of tyrosine at the amino group or the carboxy group, any substitution of phenyl hydrogens, or from the replacement of any hydrogen of tyrosine by a heteroatom. The definition normally excludes peptides containing tyrosine residues.
ChEBI ID: 62761
Members (14)
| Member | Definition | Role |
|---|---|---|
| 2-acetamido-3-(4-hydroxyphenyl)propanoic acid ethyl ester | 2-acetamido-3-(4-hydroxyphenyl)propanoic acid ethyl ester | |
| 3-fluorotyrosine | 3-fluorotyrosine | |
| 3-methoxytyrosine | 3-Methoxytyrosine | |
| clovamide | trans-Clovamide | |
| dihydroxyphenylalanine | A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring. | dopa |
| dityrosine | A biphenyl compound comprising two tyrosine residues linked at carbon-3 of their benzene rings. | dityrosine |
| etilevodopa | etilevodopa | |
| levodopa methyl ester | melevodopa | |
| n-acetyltyrosine, (dl)-isomer | An N-acetyl-amino acid that is tyrosine with an amine hydrogen substituted by an acetyl group. | N-acetyltyrosine |
| n-stearoyltyrosine | N-Stearoyl tyrosine | |
| n-trans-p-coumaroyl-l-tyrosine | trans-Dideoxyclovamide | |
| o-methyltyrosine | A tyrosine derivative that is tyrosine in which the hydroxy group at position 4 of the phenyl ring is substituted by a methoxy group. | O-methyltyrosine |
| Phthalyltyrosine | Phthalyltyrosine | |
| thyroxine | An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions. | thyroxine zwitterion; thyroxine |
Research
Studies (8,997)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5,611 (62.37) | 18.7374 |
| 1990's | 1,258 (13.98) | 18.2507 |
| 2000's | 980 (10.89) | 29.6817 |
| 2010's | 888 (9.87) | 24.3611 |
| 2020's | 260 (2.89) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 374 (3.87%) | 5.53% |
| Reviews | 559 (5.78%) | 6.00% |
| Case Studies | 257 (2.66%) | 4.05% |
| Observational | 7 (0.07%) | 0.25% |
| Other | 8,467 (87.61%) | 84.16% |